GreenJay Therapeutics
Accelerating the development of new formulations for hematological diseases designed to:.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJun 8, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- BSBorje S. Andersson Scientific Founder and Member of Board of Directors, Corporate Secretarysource: greenjaytherapeutics.com
Similar Health and bio companies
PProxy Foods$6M Seed · Aug 2026
MMendra$82M Series A · Jan 2026VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/greenjay-therapeutics (get a free API key).